Nursing Care Management for Coagulation Disorders Quiz

Deficiency in clotting factor VIII leads to impaired coagulation, characteristic of Hemophilia A.

The primary nursing goal is to prevent injury and bleeding in patients with coagulation disorders to minimize complications.

Hemophilia B results from a deficiency in clotting factor IX, leading to impaired coagulation.

INR is utilized to monitor the therapeutic effect of warfarin, ensuring appropriate anticoagulation levels.

Joint pain and swelling are characteristic symptoms of hemophilia due to recurrent bleeding into joints.

Factor VIII concentrate is administered to replenish deficient clotting factors in hemophilia management.

Administering factor replacement therapy is crucial to address bleeding episodes in hemophilia patients.

aPTT is utilized to monitor heparin therapy due to its sensitivity in assessing clotting activity.

Thrombocytopenia often presents with easy bruising and bleeding due to low platelet count.

Avoiding IM injections reduces the risk of bleeding in patients receiving anticoagulant therapy due to increased bleeding susceptibility.

Von Willebrand Disease results from a deficiency in Von Willebrand Factor, essential for platelet function and clotting.

Untreated hemophilia may result in intracranial hemorrhage due to spontaneous bleeding, posing a severe complication.

DIC manifests as abnormal bleeding and clotting concurrently, indicative of its complex pathophysiology.

DIC is primarily caused by widespread activation of coagulation pathways, leading to excessive clotting within small blood vessels.

Administering factor replacement therapy is vital to manage severe bleeds in Von Willebrand Disease, addressing the underlying deficiency.

Addressing the underlying cause of DIC is the primary nursing intervention to halt the pathological coagulation process.

Protamine sulfate is commonly used to reverse the anticoagulant effect of heparin by binding to and neutralizing its activity.